EU AI Act — Transparency Disclosure

Regulation (EU) 2024/1689 (the AI Act) — Edition: 2026-05-26

1. Provider identification

Provider of the AI system: Project Line, emil.mamadov@projectlineil.com.

2. AI components present in the Service

3. Risk classification under Annex III

The Service is positioned as a documentation and workflow tool. Clinical-decision-support functions surface information to the licensed clinician for their independent review and decision. The treating clinician retains exclusive medical authority; the Service does not autonomously triage, diagnose, prescribe, or refuse care. On that basis the Service is operated as NOT a high-risk AI system under Annex III(5)(a).

If a clinic elects to use AI output to make autonomous clinical decisions, the clinic itself becomes the מפעיל (deployer) of a high-risk AI system under Art. 26 AI Act and assumes the corresponding obligations. The Service Agreement prohibits this use.

4. Art. 50 transparency obligations met

5. General-purpose AI model sources

ComponentProviderModelStatus
Voice + chatOpenAIGPT-Realtime familyGPAI provider — see openai.com/policies
Image OCROpenAIGPT-Realtime family (vision)GPAI provider

6. Quality management

Internal quality-management system covers data governance, log retention, change management, and post-market monitoring. Incidents are recorded in Project Line's internal log and material AI-related incidents are reported to clinic controllers within 72 hours.

7. Right to human intervention

Every AI output is reviewable and editable by the treating clinician. Patients always reach a human contact through the clinic; the AI voice agent transfers to a human on request.

8. Updates

This disclosure is updated whenever a new AI capability is added or a model provider changes. Material changes are announced under the sub-processor change procedure.